Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Kyle Welborn
AddedMar 31, 2024
UpdatedMay 31, 2026
Kyle Welborn

Kyle Welborn

Board Member, Eiwa

CrunchbaseLinkedIn

Kyle Welborn's Career

Eiwa
Eiwa

St. Louis, MO, US

Board Member· Board
Ascribe Bioscience
Ascribe Bioscience

Ithaca, NY, US

Board Member· Board
NanoGuard Technologies
NanoGuard Technologies

St. Louis, MO, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Kyle Welborn's Career

Eiwa
Eiwa
$3.4M862013St. Louis, MO, US
Board Member· Board

Leadership at Eiwa

Nicolas OtamendiNicolas OtamendiFounder
Tomás PeñaTomás PeñaBoard Member

Similar to Eiwa

AGToolsAGToolsIrvine, CA, USData Analyticsest. 2017AGToolsIrvine, CA, US · est. 2017

AgTools: Providing real-time, game-changing data analysis for the agriculture market.

$120k39
Main Street DataMain Street DataMission, KS, USData Analyticsest. 2016Main Street DataMission, KS, US · est. 2016

Main Street Data: Transforming agriculture with precise, data-driven science and innovative products.

$5.6M7
Digital GaiaDigital GaiaGreenwood Village, CO, USData, Softwareest. 2022Digital GaiaGreenwood Village, CO, US · est. 2022

Digital Gaia: AI-powered network optimizing agriculture for food security and nature preservation.

$250k7
Geovisual TechnologiesGeovisual TechnologiesBoulder, CO, USAnalytics, Softwareest. 2000Geovisual TechnologiesBoulder, CO, US · est. 2000

AI-driven GeoVisual analytics provider for efficient farm monitoring via drones, planes, and mobiles.

$750k5
Ascribe Bioscience
Ascribe Bioscience
$7.2M82017Ithaca, NY, US
Board Member· Board

Leadership at Ascribe Bioscience

Jay FarmerJay FarmerCo-Founder
Murli ManoharMurli ManoharCo-Founder

Similar to Ascribe Bioscience

AgBiomeAgBiomeTriangle (historical), NC, USCrop Protection, Fungicidesest. 2012AgBiomeTriangle (historical), NC, US · est. 2012

US-based AgBiome innovates in crop protection through biological and trait product development.

$252.5M139
Ascus BiosciencesAscus BiosciencesSan Diego, CA, USMicrobial Productsest. 2015Ascus BiosciencesSan Diego, CA, US · est. 2015

Ascus Biosciences, a San Diego-based firm, pioneers in developing next-gen microbial products since 2015.

$51M30
Adaptive Symbiotic TechnologiesAdaptive Symbiotic TechnologiesSeattle, WA, USAgricultural Productsest. 2011Adaptive Symbiotic TechnologiesSeattle, WA, US · est. 2011

Seattle-based biotech firm specializing in symbiotic plant microbes for enhanced crop yield.

$4.5M17
AgrynexAgrynexIthaca, NY, USBiopesticides, Crop Protectionest. 2015AgrynexIthaca, NY, US · est. 2015

Agrynex: Providing biocidal enzymes for crop protection against soil-borne diseases.

$50k4
NanoGuard Technologies
NanoGuard Technologies
$10.7M112014St. Louis, MO, US
Board Member· Board

Leadership at NanoGuard Technologies

Mark HochwaltMark HochwaltFounder
Larry ClarkeLarry ClarkeCEO
John PeryamJohn PeryamBoard Member

People Similar to Kyle Welborn

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoBrian KimBrian KimBoard Member · KakaoBill YoungBill YoungBoard Member · Theravance BiopharmaLarry DuboisLarry DuboisCo-Founder · NanoionixPeter GlickPeter GlickBoard Member · Meadowhawk BiolabsSteve GoldbySteve GoldbyBoard Member · Transonic Combustion